Skip to content
MarketScale
‹ Back to IndustriesSciences

Metrology Matters: 2D and 3D Surface Parameters – Should You Stick to the Typical Results?

The episode of Metrology Matters discusses insights on 2D and 3D surface parameter measurements with experts Dr. Mark Mulberg and Carl Musolff. It highlights the importance of these parameters in design and metrology.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Digital MetrologyMeasureMetrologyMetrology Matters
Share

Key takeaways

01

Experts provide insights on 2D and 3D surface parameter measurements.

02

Designers use various surface texture parameters for accuracy.

03

Metrology expertise is crucial for optimized measurements.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

This episode of Metrology Matters features two bona fide experts in the field in Digital Metrology’s Dr. Mark Mulberg and Musolff Consulting’s Carl Musolff – and they’ve got front-line insights to share about getting the most out of 2D and 3D surface parameter measurements.

Currently, designers and companies specify surface texture parameters in a multitude of ways, though a common method is to leverage older, similar designs and modify as necessary based on more demanding environments, etc. However, this is often an inexact science – and a headache-inducing one.

Though the most expensive option, testing is the most accurate method for determining what works and what doesn’t. Measuring a part, putting it through rigors similar to what it will actually undergo on the job, and measuring again is really the only surefire way to get the clearest picture of its performance.

Another key consideration that Malburg said is often overlooked is waviness – in fact, he said a colleague calls it “the hidden killer.”

The trio continued to explore best practices and innovations in surface metrology, diving into why the shape of a surface is more important than its roughness, the importance of interacting with a surface and learning how its shape can impact its function, and why appreciating a surface visually helps you appreciate and understand its many critical attributes.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers has terminated its agreement with Cellares, which raises concerns about the standardized capacity for cell therapy production. This decision highlights the importance of aligning manufacturing processes with production capabilities, rather than merely focusing on the availability of factory slots.

  • 01Bristol Myers has terminated its agreement with Cellares, affecting cell therapy capacity.
  • 02Aligning process fit with production capabilities is crucial for cell therapy success.
  • 03Factory slots alone are not sufficient to ensure supply plans in cell therapy production.

Aug 26, 2026

Argonne’s AI agents push materials R&D toward days-long cycles

Argonne’s AI agents push materials R&D toward days-long cycles

Argonne National Laboratory is utilizing AI agents to accelerate materials R&D cycles, reducing the time span to just a few days. This advancement hinges on prioritizing dataflow and security over larger AI models. The novel approach aims to streamline processes and enhance the efficiency of research and development activities.

  • 01Argonne National Laboratory is using AI agents to significantly shorten materials R&D cycles.
  • 02The focus of procurement has shifted to dataflow and security rather than larger AI models.
  • 03Improved workflows facilitate more efficient research and development efforts.

Aug 25, 2026

Cancer diagnostics growth is forcing labs to budget for data, not just instruments

Cancer diagnostics growth is forcing labs to budget for data, not just instruments

The growth in cancer diagnostics is prompting laboratories to allocate budgets not only for instruments but also for data management. Market forecasts predict an increase in the cancer diagnostics market from $29.86 billion in 2026 to $44.92 billion by 2031. Staffing is identified as a significant operational constraint according to industry insights.

  • 01Cancer diagnostics market is expected to grow from $29.86 billion in 2026 to $44.92 billion by 2031.
  • 02Laboratories are increasingly required to budget for data management alongside instruments.
  • 03Staffing is a major operational constraint in the growth of cancer diagnostics.

Aug 24, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

S
Sciences
DM
Dr. Mark Mulberg

Expert

Digital Metrology

CM
Carl Musolff

Consultant

Musolff Consulting

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512